(June 21, 2017) – BVGH is launching the African Access Initiative (AAI) at the Biotechnology Innovation Organization (BIO) International Convention in San Diego. AAI will expand access to oncology medicines and improve cancer care in Africa. Led by BVGH in partnership with Pfizer, Inc., Takeda Pharmaceutical Co., Ltd., and the African Organisation for Research and Training in Cancer (AORTIC), AAI will expand access to oncology medicines and improve cancer care in Africa. Click here to read more.